Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Ligand Pharmaceuticals Incorporated stock | $140.2

Learn how to easily invest in Ligand Pharmaceuticals Incorporated stock.

Ligand Pharmaceuticals Incorporated is a biotechnology business based in the US. Ligand Pharmaceuticals Incorporated shares (LGND) are listed on the NASDAQ and all prices are listed in US Dollars. Ligand Pharmaceuticals Incorporated employs 155 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Ligand Pharmaceuticals Incorporated

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LGND – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Ligand Pharmaceuticals Incorporated stock price (NASDAQ: LGND)

Use our graph to track the performance of LGND stocks over time.

Ligand Pharmaceuticals Incorporated shares at a glance

Information last updated 2021-10-23.
Latest market close$140.20
52-week range$78.26 - $219.75
50-day moving average $134.30
200-day moving average $128.43
Wall St. target price$207.86
PE ratio 47.1755
Dividend yield N/A (0%)
Earnings per share (TTM) $2.89

Buy Ligand Pharmaceuticals Incorporated shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ligand Pharmaceuticals Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ligand Pharmaceuticals Incorporated price performance over time

Historical closes compared with the close of $140.2 from 2021-10-26

1 week (2021-10-16) N/A
1 month (2021-09-23) N/A
3 months (2021-07-27) 16.43%
6 months (2021-04-27) -7.20%
1 year (2020-10-27) 62.68%
2 years (2019-10-25) 25.93%
3 years (2018-10-26) 167.06
5 years (2016-10-27) 50.20%

Is Ligand Pharmaceuticals Incorporated under- or over-valued?

Valuing Ligand Pharmaceuticals Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ligand Pharmaceuticals Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ligand Pharmaceuticals Incorporated's P/E ratio

Ligand Pharmaceuticals Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, Ligand Pharmaceuticals Incorporated shares trade at around 47x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Ligand Pharmaceuticals Incorporated's PEG ratio

Ligand Pharmaceuticals Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.9849. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ligand Pharmaceuticals Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Ligand Pharmaceuticals Incorporated's EBITDA

Ligand Pharmaceuticals Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $77.6 million.

The EBITDA is a measure of a Ligand Pharmaceuticals Incorporated's overall financial performance and is widely used to measure a its profitability.

Ligand Pharmaceuticals Incorporated financials

Revenue TTM $251.7 million
Operating margin TTM 13.87%
Gross profit TTM $96.6 million
Return on assets TTM 1.75%
Return on equity TTM 6.47%
Profit margin 19.03%
Book value $47.17
Market capitalisation $2.3 billion

TTM: trailing 12 months

Shorting Ligand Pharmaceuticals Incorporated shares

There are currently 1.7 million Ligand Pharmaceuticals Incorporated shares held short by investors – that's known as Ligand Pharmaceuticals Incorporated's "short interest". This figure is 2.4% down from 1.8 million last month.

There are a few different ways that this level of interest in shorting Ligand Pharmaceuticals Incorporated shares can be evaluated.

Ligand Pharmaceuticals Incorporated's "short interest ratio" (SIR)

Ligand Pharmaceuticals Incorporated's "short interest ratio" (SIR) is the quantity of Ligand Pharmaceuticals Incorporated shares currently shorted divided by the average quantity of Ligand Pharmaceuticals Incorporated shares traded daily (recently around 351800.40567951). Ligand Pharmaceuticals Incorporated's SIR currently stands at 4.93. In other words for every 100,000 Ligand Pharmaceuticals Incorporated shares traded daily on the market, roughly 4930 shares are currently held short.

However Ligand Pharmaceuticals Incorporated's short interest can also be evaluated against the total number of Ligand Pharmaceuticals Incorporated shares, or, against the total number of tradable Ligand Pharmaceuticals Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ligand Pharmaceuticals Incorporated's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Ligand Pharmaceuticals Incorporated shares in existence, roughly 100 shares are currently held short) or 0.1461% of the tradable shares (for every 100,000 tradable Ligand Pharmaceuticals Incorporated shares, roughly 146 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ligand Pharmaceuticals Incorporated.

Find out more about how you can short Ligand Pharmaceuticals Incorporated stock.

Ligand Pharmaceuticals Incorporated share dividends

We're not expecting Ligand Pharmaceuticals Incorporated to pay a dividend over the next 12 months.

Have Ligand Pharmaceuticals Incorporated's shares ever split?

Ligand Pharmaceuticals Incorporated's shares were split on a 1:6 basis on 18 November 2010. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ligand Pharmaceuticals Incorporated shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Ligand Pharmaceuticals Incorporated shares which in turn could have impacted Ligand Pharmaceuticals Incorporated's share price.

Ligand Pharmaceuticals Incorporated share price volatility

Over the last 12 months, Ligand Pharmaceuticals Incorporated's shares have ranged in value from as little as $78.26 up to $219.75. A popular way to gauge a stock's volatility is its "beta".

LGND.US volatility(beta: 1.09)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ligand Pharmaceuticals Incorporated's is 1.0878. This would suggest that Ligand Pharmaceuticals Incorporated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Ligand Pharmaceuticals Incorporated overview

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company's commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for the treatment of osteoporosis; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of PPD; Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney, and other diseases. In addition, the company is involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated was founded in 1987 and is headquartered in Emeryville, California. .

Ligand Pharmaceuticals Incorporated in the news

There are no recent company news

Frequently asked questions

What percentage of Ligand Pharmaceuticals Incorporated is owned by insiders or institutions?
Currently 4.828% of Ligand Pharmaceuticals Incorporated shares are held by insiders and 96.872% by institutions.
How many people work for Ligand Pharmaceuticals Incorporated?
Latest data suggests 155 work at Ligand Pharmaceuticals Incorporated.
When does the fiscal year end for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated's fiscal year ends in December.
Where is Ligand Pharmaceuticals Incorporated based?
Ligand Pharmaceuticals Incorporated's address is: 5980 Horton Street, EmeryVille, CA, United States, 94608
What is Ligand Pharmaceuticals Incorporated's ISIN number?
Ligand Pharmaceuticals Incorporated's international securities identification number is: US53220K5048
What is Ligand Pharmaceuticals Incorporated's CUSIP number?
Ligand Pharmaceuticals Incorporated's Committee on Uniform Securities Identification Procedures number is: 53220K173

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site